Increased protein O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) has emerged as a hallmark of mammalian cell activation, contributing to Warburg-like metabolic rewiring allowing the acquisition of new functionalities. Recent advances indicate that O-GlcNAcylation promotes the activity of transcriptional regulators driving gene expression reprogramming. This may offer new therapeutic opportunities in a broad spectrum of pathological conditions.
Keywords: O-GlcNAcylation; chronic diseases; metabolic reprogramming; pathophysiological cell activation; transcriptional regulators; transcriptional reprogramming.
Copyright © 2024 Elsevier Ltd. All rights reserved.